Immunologic effects of BCG in patients with malignant melanoma: specific evidence for stimulation of the 'secondary' immune response
Chess, L.; Bock, G.N.; Ungaro, P.C.; Buchholz, D.H.; Mardiney, M.R.
Journal of the National Cancer Institute 51(1): 57-65
1973
ISSN/ISBN: 0027-8874 PMID: 4720886 Document Number: 66018
Document emailed within 1 workday
Related Documents
Nĕmecková, S.; Bubeník, J.; Jezek, J.; Zaoral, M. 1982: Stimulation of non-specific resistance and specific immune response against tumours in mice by synthetic muramyl dipeptide Folia Biologica 28(5): 327-333Mutsenietse, A.I.; Volrat, A.A.; Popena, B.A.; Bumbieris, I.V.; Shapovalova, E.A. 1983: Immunologic response in patients with melanoma of the skin Voprosy Onkologii 29(4): 34-38
Thatcher, N.; Swindell, R.; Crowther, D. 1979: Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly sequential study of melanoma patients. I. Changes in non-specific (NK, K and T cell) lymphocytotoxicity, peripheral blood counts and delayed hypersensitivity reactions Clinical and Experimental Immunology 36(2): 227-236
Kovarík, J.; Ninger, E.; Mechl, Z.; Zemanová, D.; Lauerová, L.; Sopková, B.; Svejda, J.; Bacovský, B.; Bártová, A.; Bártek, J. 1983: Immunotherapy and immune competence of patients with malignant melanoma Czechoslovak Medicine 6(3): 172-174
Rodák, L. 1976: A histoautoradiographic study of the localization of antigen and specific antibodies in the rabbit spleen. I. Comparison of the primary and secondary immune response Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 151(1-2): 46-60
Arlen, M.; Hollinshead, A.; Scherrer, J. 1977: Tumor-specific immunity in patients with malignant melanoma Surgical Forum 28: 168-169
The, T.H.; van der Giessen, M.; Huiges, H.A.; Schraffordt Koops, H.; van Wingerden, I. 1978: Immune complexes in peripheral blood polymorphonuclear leucocytes of malignant melanoma patients Clinical and Experimental Immunology 32(3): 387-391
Kalafut, F.; Cernák, A.; Pham Manh Hung 1979: Detection of specific immunoreactivity by LAi assay in patients with malignant melanoma of uveal tissue Neoplasma 26(3): 299-305
Lynn, W.A.; Raetz, C.R.; Qureshi, N.; Golenbock, D.T. 1991: Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists Journal of Immunology 147(9): 3072-3079
Veresova, O.V.; Korosteleva, T.A. 1975: Immunologic reactions in malignant melanoma of the skin in man Voprosy Onkologii 21(4): 74-80
Bickhardt, R.; Kunze, J. 1974: Immunologic reaction-readiness in malignant melanoma Zeitschrift für Hautkrankheiten 49(8): 315-333
Carlson, G.A.; Terres, G. 1978: The effects of passive immunization with tumor-specific antiserum on the active immune response of mice to sublines of leukemia L1210 Journal of Immunology 121(5): 1752-1759
Zola, H. 1974: Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen Clinical and Experimental Immunology 16(3): 469-479
Saha, G.K. 1994: Relationship between Dermatophagoides mite density and specific immune response in asthmatic patients Annals of Allergy 73(5): 429-433
Crişan, M.; Stugren, C.; Gal, O.; Herold, A.; Bucurenci, N. 1992: In vivo effects of thymic hormones (Imunotim) on immunologic parameters of patients with secondary immunodeficiency diseases Roumanian Archives of Microbiology and Immunology 51(4): 213-224
Morton, D.L. 2004: Immune response to postsurgical adjuvant active immunotherapy with Canvaxin polyvalent cancer vaccine: correlations with clinical course of patients with metastatic melanoma Developments in Biologicals 116: 209
Miura, T.; Ishikawa, S. 1970: Malignant melanoma--synopses from the seminar on malignant melanoma by International Group for the Clinical Study of Melanoma Gan no Rinsho. Japan Journal of Cancer Clinics 16(11): 1064-1070
Shalev, Y.; Bentwich, Z.; Katz, D.; Brautbar, C.; Mozes, E. 1986: Antigen specific immune response potential and HLA typing of Israeli patients with thyroid autoimmune diseases (TAD) Clinical and Experimental Immunology 64(2): 255-260
Nishio, S.; Asakawa, M.; Tanaka, S.; Wada, S.; Maekawa, M.; Kawamura, M. 1986: Studies on the cellular immune response in patients with urinary bladder carcinoma. XI: Evaluation of specific ADCC activity Hinyokika Kiyo. Acta Urologica Japonica 32(5): 713-720
Hartmann, D.W.; Robinson, W.A.; Mangalik, A.; Glode, L.M.; Triebel, F. 1981: Unanticipated side effects from treatment with high-dose mechlorethamine in patients with malignant melanoma Cancer Treatment Reports 65(3-4): 327-328